Corcept Therapeutics
CORT
Rank 3273
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 149 COMMONWEALTH DRIVE, MENLO PARK, CA, US
Corcept Therapeutics - Key figures
Market cap 2.53 Billion
Revenue 380.23 Million
Profit 360.7 Million
P/E Ratio 26.04
P/s Ratio 6.65
Corcept Therapeutics - Description
Corcept Therapeutics Incorporated discovers, develops, and markets drugs for the treatment of severe metabolic, cancer, and psychiatric disorders in the United States.
The company is headquartered in Menlo Park, California.